Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5542 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 41 42 43 ... 54 55 56  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
ETH Zürich–Agilent: gel electrophoresis, 201111 supply existent Agilent 3100 OFFGEL fractionator at Aebersold Lab 2011-11-18
ETH Zürich–Thermo Fisher: mass spectrometer, 201111 supply existent Orbitrap Velos at Aebersold Lab 2011-11-18
Biocartis–SEVERAL: investment, 201111 financing round Series C €71m 2011-11-17
Sygnis–Cenix BioScience: drug discovery services, 201111– supply service €na screening + target validation for CNS drugs 2011-11-17
Agennix–SEVERAL: investment, 201111–201112 capital increase €27.5m with €11.3m in cash + €16.2m through loan conversion by Dievini Hopp BioTech 2011-11-16
OracleBio–Definiens: bioinformatics, 201111 supply existent use of Tissue Studio s/w for tissue biomarker + morphological profiling 2011-11-16
Takara Shuzo–Eppendorf: thermal cycler, 201111– license covering gradient technology for thermal cyclers to Takara Bio Inc 2011-11-15
BIONEXGEN project–BASF: biocatalysts, 201111 BASF is project partner in FP7 project 2011-11-14
BIONEXGEN project–EU (govt): grant, 201111 grant BIONEXGEN is ongoing FP7 project 2011-11-14
Deutsche Gesellschaft Industrielle Zelltechnik–CellGenix: industrial cell technology, 201111– membership CellGenix GmbH 2011-11-14
Nanohale–SEVERAL: investment, 201111–201112 capital increase €2.4m with 336,668 new shares €7/share 2011-11-14
Probiodrug–Russo Partners: public relations, 201111 service existent by Russo Partners LLC 2011-11-14
Inscreenex–Germany (govt): grant, 201111– 3y KMU-innovativ BioChance grant from BMBF to design human liver cell systems using CI-SCREEN technology 2011-11-11
CytoTools–SEVERAL: investment, 201111 capital increase €3.2m 237,650 new shares €13.3/share 2011-11-10
Direvo Industrial Biotechnology–College Group: public relations, 201111 service existent by College Hill Life Sciences 2011-11-09
Partec–De Novo Software: flow cytometry s/w, 201111– distribution of FCS Express s/w with CyFlow Cube system + ww resale of FCS Express by Partec 2011-11-09
Affiris–MIG Fonds: investment, 201111 capital increase €5m sold to MIG 11 Fund 2011-11-08
Affiris–Strüngmann Group: investment, 201111 capital increase €20m sold to Santo VC GmbH 2011-11-08
ComplexINC project–Crelux: recombinant protein production technology, 201111– Crelux GmbH is partner + co-coordinator of FP7 EU Project 2011-11-01
ComplexINC project–EU (govt): grant, 201111– FP7 grant €5.9m for 4y project 2011-11-01
Lonza–Trenzyme: cell line technology, 201111– license to Lonza 2011-11-01
Merck (DE)–Ablynx: Nanobodies, 201111– collab co-discovery + co-developm Nanobodies against two targets in osteoarthritis Merck Serono 2011-11-01
Metrohm–Analytik Jena: analytical instruments, 2011–201312 distribution Metrohm India Ltd excl sales partner for AJ products in India 2011-11-01
Biognosys–Redalpine: investment, 201110 financing round Series A totalling CHF2.7m incl investor Redalpine Capital I 2011-10-31
Biognosys–SEVERAL: investment, 201110 financing round Series A CHF2.7m from Syngenta Ventures + Redalpine Capital I + ZKB + private investors 2011-10-31
Addex–Halsin Partners: public relations, 201110 service existent Addex listed as client on Halsin web site 2011-10-30
Epigenomics–Halsin Partners: public relations, 201110 service existent Epigenomics listed as client on Halsin web site 2011-10-30
Gene Signal–Halsin Partners: public relations, 201110 service existent Gene Signal listed as client on Halsin web site 2011-10-30
Charles River–Protagen: proteomic services, 201110– collab marketing + sales alliance of Protagen services w Charles River preclinical services 2011-10-28
Diatech–Anagnostics: molecular diagnostics, 201110– license KRAS test sale in Italy to Cell.ENG + co-developm Hybcell tests w Diatech Pharmacogenetics 2011-10-27
iThera Medical–Helmholtz: IP services, 201110 existent IP asset management support by Ascenion GmbH 2011-10-27
iThera Medical–SEVERAL: investment, 201110c financing round Series A led by BayBG + Mey Capital Matrix GmbH 2011-10-27
Biohit–Sartorius: investment, 201110–201112 acquisition of liquid handling business for €68m in cash 2011-10-26
Curetis–SEVERAL: investment, 201110 financing round Series A 2nd extension additional €9.6m incl new investors Forbion + Roche Venture Fund 2011-10-26
Inhibrx–Minapharm: GlymaxX technology, 201110– multi-program license + services €na for therapeutic antibody develpm from ProBioGen AG 2011-10-25
Abbott–Axis-Shield: anti-CCP test, 201110 license existent 2011-10-21
Siemens–Axis-Shield: anti-CCP test, 201110– license for use on ADVIA Centaur Immunoassay System to Siemens Healthcare Diagnostics 2011-10-21
Apeiron–Evotec: drug discovery services, 201110– collab €na identification of molecules targeting Cbl-b for anti-tumor immune therapy 2011-10-20
Deutsche Gesellschaft Industrielle Zelltechnik–Cellasys: industrial cell technology, 201110– membership Cellasys GmbH 2011-10-20
Hookipa–Forbion: investment, 201110 financing round Series A €7m incl Forbion Capital Partners + Sofinnova Partners 2011-10-18
Hookipa–SEVERAL: investment, 201110 financing round Series A €7m incl Forbion Capital Partners + Sofinnova Partners 2011-10-18
Hookipa–Sofinnova: investment, 201110 financing round Series A €7m incl Forbion Capital Partners + Sofinnova Partners 2011-10-18
Population Genetics–SEVERAL: investment, 201110 financing round Series B $5.7m incl Syngenta Ventures + Compass Genetics + Wellcome Trust et al 2011-10-18
Syngenta–Population Genetics: plant genetics, 201110– collab use of PG diagnostic genetic technology for plant breeding 2011-10-18
Anadys–Roche: investment, 201110–201111 acquisition $230m cash tender offer $3.70/share 2011-10-17
Univ Surrey–Bruker Corp: mass spectrometer, 201110 supply existent AutoFlex MALDI-TOF MS listed on web site of mass spec core facility 2011-10-14
Priaxon–Ontochem: PARP inhibitors, 201110– collab + commercialisation agreem to increase stress tolerance of crops 2011-10-12
Dichrom–Protea Biosciences: LAESI technology, 201110– marketing of LAESI technology in Europe by Dichrom GmbH 2011-10-11
RainDance–Sony: microfluidics technology, 201110 supply existent lab-on-chip-technology for RainDance technology platform by Sony DADC 2011-10-11
Shimadzu–Sony: MALDI targets, 201110 supply existent OEM single-use MALDI targets to Kratos by Sony DADC 2011-10-11
Apceth–Commpartners: public relations, 201110 supply service existent 2011-10-10
CorTec–SEVERAL: investment, 201110 seed financing round <€2.4m w investors HTGF + Seedfonds BW + K & S W Invest 2011-10-10
Humedics–SEVERAL: investment, 201110 1st financing round €1.2m Charité Biomedical Fund + VC Fonds Technologie + KfW + HTGF + Ventegis 2011-10-10
Anagnostics–Sony: Hybcell technology, 201110– collab contract manufacturing components for Hybcell kits + co-developm by Sony DADC Austria GmbH 2011-10-07
LipoFIT–SEVERAL: investment, 201110 2nd financing round €7m from SHS + KfW + Bayern Kapital + private investor 2011-10-07
Microstim–SEVERAL: investment, 201110 financing round €1.5m MVP + HTGF + Fides Finanz-Invest 2011-10-06
UCB–Evotec: drug discovery services, 201110– collab €na multi-year identification of small molecules for multiple targets in immunology 2011-10-05
Univ Minnesota–Bruker Corp: mass spectrometer, 201110 supply existent BioTOF II with Agilent 1100 LC at Mass Spec Facility 2011-10-04
Univ Minnesota–Bruker Corp: mass spectrometer, 201110 supply existent micrOTOF-Q with Agilent 1100 LC at Mass Spec Facility 2011-10-04
Univ Minnesota–Bruker Corp: mass spectrometer, 201110 supply existent Reflex III reflectron MALDI-TOF at Mass Spec Facility 2011-10-04
Univ Minnesota–Thermo Fisher: mass spectrometer, 201110 supply existent MAT 95 double-focusing HR MS with HP 5890 GC at Mass Spec Facility 2011-10-04
Univ Minnesota–Waters: mass spectrometer, 201110 supply existent VG 70SE double-focusing HR MS with HP 5890 GC at Mass Spec Facility 2011-10-04
ADITEC project–EU (govt): grant, 201110–201609 funding €29.98m from EU out of total project cost of €41m 2011-10-01
Beun-de Ronde–SAW Instruments: acoustic biosensor, 201110 distribution existent of sam biosensors in Belgium by Beun-de Ronde Serlabo BVBA 2011-10-01
BLUEPRINT project–EU (govt): grant, 201110–201603 funding €30m from EU out of total project cost of €40m 2011-10-01
BLUEPRINT project–Genomatix Software: epigenomics research, 201110–201603 partner in €30m FP7 project responsible for data analysis 2011-10-01
DI Biotech–SAW Instruments: acoustic biosensor, 201110– distribution of sam biosensors in Korea by DI Biotech Ltd 2011-10-01
EUROCALIN Consortium–EU (govt): grant, 201110c– FP7 grant €6m for anticalin development to treat anemia 2011-10-01
EUROCALIN Consortium–Pieris: Anticalin therapeutic, 201110c– collab Pieris is member + co-ordinator of FP7 project to develop PRS-080 to treat anemia 2011-10-01
Gene Company–SAW Instruments: acoustic biosensor, 201110 distribution existent of sam biosensors in China by Gene Company Ltd 2011-10-01
MEHTRICS project–Cenix BioScience: cell-based assays, 201110–201409 collab Cenix BioScience GmbH is partner in EU FP7 project 2011-10-01
MEHTRICS project–Cytoo: cell-based assays, 201110–201409 collab Cytoo SA is partner in EU FP7 project 2011-10-01
MEHTRICS project–EU (govt): grant, 201110–201409 FP7 grant €4.36m developm cell-based RNAi assays incl Cytoo SA + Cenix BioScience GmbH as SMEs 2011-10-01
MEHTRICS project–Vitamib: project management, 201110–201409 collab Vitamib SAS is partner in EU FP7 project 2011-10-01
Merck (DE)–Ono Pharmaceutical: ceralifimod, 201110–201406 license ww excl except JP + KR + Taiwan TERMINATED 6/14 2011-10-01
DIL–Evotec: investment, 201109 acquisition €1.7m in cash remaining 30% of Evotec (India) Pvt Ltd (RSIPL) from DIL Ltd 2011-09-29
SPECTARIS–MeVis: analytical technology, 201109– membership MeVis Medical Solutions AG joins SPECTARIS e. V. 2011-09-28
CLC bio–Biobase: genomic software, 201109– collab integration of Genome Trax databases into Genomics Gateway framework 2011-09-27
MorphoSys–Genedata: bioinformatics, 201109– supply license to Genedata Biologics data management platform 2011-09-27
Univ Groningen–SAW Instruments: SAW biosensor, 201109 supply set up of sam5 system at Univ of Groningen 2011-09-27
Protaffin–College Group: public relations, 201109 service existent by College Hill Life Sciences 2011-09-26
Univ Bern–Bruker Corp: mass spectrometer, 201109 supply existent Esquire3000plus at PMSCF 2011-09-25
Univ Bern–GeneBio: mass spectrometry software, 201109 supply existent Phenyx s/w used at PMSCF 2011-09-25
Univ Bern–Thermo Fisher: mass spectrometer, 201109 supply existent LTQ-Orbitrap-XL with ETD at PMSCF 2011-09-25
Almirall–Proteros: drug discovery services, 201109– collab research identification of small molecule inhibitors to inflammatory target 2011-09-22
Lipocalyx–GoodVent: investment, 201109 seed financing round with High-Tech Gründerfonds + GoodVent 2011-09-21
Lipocalyx–High-Tech Gründerfonds: investment, 201109 seed financing round with High-Tech Gründerfonds + GoodVent 2011-09-21
Lipocalyx–SEVERAL: investment, 201109 seed financing round with High-Tech Gründerfonds + GoodVent 2011-09-21
Boehringer–Nuevolution: drug discovery services, 201109– collab €na using Chemetics technology to discover compounds against Boehringer targets 2011-09-20
4-Antibody–College Group: public relations, 201109 service existent by College Hill Life Sciences 2011-09-19
BF Holding–SEVERAL: investment, 201109 private placement MagForce AG €700k capital increase 56,360 new shares €12.42/share 2011-09-19
Merck (DE)–Peptimmune: PI-2301, 201109 acquisition ww excl rights from bankrupt Peptimmune Inc 2011-09-19
Nabriva–College Group: public relations, 201109 service existent by College Hill Life Sciences 2011-09-19
EndoSense–Ysios Capital: investment, 201109 existent listed as portfolio company on web site 2011-09-17
CRP-Santé–Thermo Fisher: mass spectrometer, 201109 supply existent Q Exactive early user Bruno Domon at Luxembourg Clinical Proteomics unit 2011-09-16
Roche–Uppsala BIO: drug discovery, 201109– strategic partnering linking Uppsala BIO-X to Roche EIN Expanding the Innovation Network 2011-09-15
Capical–High-Tech Gründerfonds: investment, 201109 seed financing from High-Tech Gründerfonds + K & S W Invest 2011-09-14
Capical–SEVERAL: investment, 201109 seed financing from High-Tech Gründerfonds + K & S W Invest 2011-09-14
Miracor–SEVERAL: investment, 201109 financing round Series B €7m 1st closing incl AWS + SHS + Earlybird + Delta Partners 2011-09-14
AM-Pharma–SEVERAL: investment, 201109 financing round Series D €29.2m led by Ysios Capital Partners co-led Kurma Life Science Partners 2011-09-13
next pagenext page 1 2 3 ... 41 42 43 ... 54 55 56  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px

» top